Cryotherapy in inflammatory rheumatic diseases

A systematic review

Xavier Guillot, Nicolas Tordi, Laurent Mourot, Céline Demougeot, Benoît Dugué, Clément Prati, Daniel Wendling

Research output: Contribution to journalReview article

41 Citations (Scopus)

Abstract

The aim of this article was to review current evidence about cryotherapy in inflammatory rheumatic diseases (therapeutic and biological effects). For therapeutic effects, we performed a systematic review (PubMed, EMBASE, Cochrane Library, LILACS databases, unpublished data) and selected studies including non-operated and non-infected arthritic patients treated with local cryotherapy or whole-body cryotherapy. By pooling 6 studies including 257 rheumatoid arthritis (RA) patients, we showed a significant decrease in pain visual analogic scale (mm) and 28-joint disease activity score after chronic cryotherapy in RA patients. For molecular pathways, local cryotherapy induces an intrajoint temperature decrease, which might downregulate several mediators involved in joint inflammation and destruction (cytokines, cartilage-degrading enzymes, proangiogenic factors), but studies in RA are rare. Cryotherapy should be included in RA therapeutic strategies as an adjunct therapy, with potential corticosteroid and nonsteroidal anti-inflammatory drug dose-sparing effects. However, techniques and protocols should be more precisely defined in randomized controlled trials with stronger methodology.

Original languageEnglish
Pages (from-to)281-294
Number of pages14
JournalExpert Review of Clinical Immunology
Volume10
Issue number2
DOIs
Publication statusPublished - 1 Feb 2014
Externally publishedYes

Fingerprint

Cryotherapy
Rheumatic Diseases
Rheumatoid Arthritis
Therapeutic Uses
Joint Diseases
PubMed
Libraries
Arthritis
Cartilage
Adrenal Cortex Hormones
Anti-Inflammatory Agents
Down-Regulation
Randomized Controlled Trials
Joints
Databases
Cytokines
Inflammation
Pain
Temperature
Enzymes

Keywords

  • cryotherapy
  • cytokines
  • DAS28
  • enzymes
  • pain VAS

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Cryotherapy in inflammatory rheumatic diseases : A systematic review. / Guillot, Xavier; Tordi, Nicolas; Mourot, Laurent; Demougeot, Céline; Dugué, Benoît; Prati, Clément; Wendling, Daniel.

In: Expert Review of Clinical Immunology, Vol. 10, No. 2, 01.02.2014, p. 281-294.

Research output: Contribution to journalReview article

Guillot, X, Tordi, N, Mourot, L, Demougeot, C, Dugué, B, Prati, C & Wendling, D 2014, 'Cryotherapy in inflammatory rheumatic diseases: A systematic review', Expert Review of Clinical Immunology, vol. 10, no. 2, pp. 281-294. https://doi.org/10.1586/1744666X.2014.870036
Guillot, Xavier ; Tordi, Nicolas ; Mourot, Laurent ; Demougeot, Céline ; Dugué, Benoît ; Prati, Clément ; Wendling, Daniel. / Cryotherapy in inflammatory rheumatic diseases : A systematic review. In: Expert Review of Clinical Immunology. 2014 ; Vol. 10, No. 2. pp. 281-294.
@article{87dd0e4ade9841e2b95710e38a411523,
title = "Cryotherapy in inflammatory rheumatic diseases: A systematic review",
abstract = "The aim of this article was to review current evidence about cryotherapy in inflammatory rheumatic diseases (therapeutic and biological effects). For therapeutic effects, we performed a systematic review (PubMed, EMBASE, Cochrane Library, LILACS databases, unpublished data) and selected studies including non-operated and non-infected arthritic patients treated with local cryotherapy or whole-body cryotherapy. By pooling 6 studies including 257 rheumatoid arthritis (RA) patients, we showed a significant decrease in pain visual analogic scale (mm) and 28-joint disease activity score after chronic cryotherapy in RA patients. For molecular pathways, local cryotherapy induces an intrajoint temperature decrease, which might downregulate several mediators involved in joint inflammation and destruction (cytokines, cartilage-degrading enzymes, proangiogenic factors), but studies in RA are rare. Cryotherapy should be included in RA therapeutic strategies as an adjunct therapy, with potential corticosteroid and nonsteroidal anti-inflammatory drug dose-sparing effects. However, techniques and protocols should be more precisely defined in randomized controlled trials with stronger methodology.",
keywords = "cryotherapy, cytokines, DAS28, enzymes, pain VAS",
author = "Xavier Guillot and Nicolas Tordi and Laurent Mourot and C{\'e}line Demougeot and Beno{\^i}t Dugu{\'e} and Cl{\'e}ment Prati and Daniel Wendling",
year = "2014",
month = "2",
day = "1",
doi = "10.1586/1744666X.2014.870036",
language = "English",
volume = "10",
pages = "281--294",
journal = "Expert Review of Clinical Immunology",
issn = "1744-666X",
publisher = "Expert Reviews Ltd.",
number = "2",

}

TY - JOUR

T1 - Cryotherapy in inflammatory rheumatic diseases

T2 - A systematic review

AU - Guillot, Xavier

AU - Tordi, Nicolas

AU - Mourot, Laurent

AU - Demougeot, Céline

AU - Dugué, Benoît

AU - Prati, Clément

AU - Wendling, Daniel

PY - 2014/2/1

Y1 - 2014/2/1

N2 - The aim of this article was to review current evidence about cryotherapy in inflammatory rheumatic diseases (therapeutic and biological effects). For therapeutic effects, we performed a systematic review (PubMed, EMBASE, Cochrane Library, LILACS databases, unpublished data) and selected studies including non-operated and non-infected arthritic patients treated with local cryotherapy or whole-body cryotherapy. By pooling 6 studies including 257 rheumatoid arthritis (RA) patients, we showed a significant decrease in pain visual analogic scale (mm) and 28-joint disease activity score after chronic cryotherapy in RA patients. For molecular pathways, local cryotherapy induces an intrajoint temperature decrease, which might downregulate several mediators involved in joint inflammation and destruction (cytokines, cartilage-degrading enzymes, proangiogenic factors), but studies in RA are rare. Cryotherapy should be included in RA therapeutic strategies as an adjunct therapy, with potential corticosteroid and nonsteroidal anti-inflammatory drug dose-sparing effects. However, techniques and protocols should be more precisely defined in randomized controlled trials with stronger methodology.

AB - The aim of this article was to review current evidence about cryotherapy in inflammatory rheumatic diseases (therapeutic and biological effects). For therapeutic effects, we performed a systematic review (PubMed, EMBASE, Cochrane Library, LILACS databases, unpublished data) and selected studies including non-operated and non-infected arthritic patients treated with local cryotherapy or whole-body cryotherapy. By pooling 6 studies including 257 rheumatoid arthritis (RA) patients, we showed a significant decrease in pain visual analogic scale (mm) and 28-joint disease activity score after chronic cryotherapy in RA patients. For molecular pathways, local cryotherapy induces an intrajoint temperature decrease, which might downregulate several mediators involved in joint inflammation and destruction (cytokines, cartilage-degrading enzymes, proangiogenic factors), but studies in RA are rare. Cryotherapy should be included in RA therapeutic strategies as an adjunct therapy, with potential corticosteroid and nonsteroidal anti-inflammatory drug dose-sparing effects. However, techniques and protocols should be more precisely defined in randomized controlled trials with stronger methodology.

KW - cryotherapy

KW - cytokines

KW - DAS28

KW - enzymes

KW - pain VAS

UR - http://www.scopus.com/inward/record.url?scp=84893076214&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84893076214&partnerID=8YFLogxK

U2 - 10.1586/1744666X.2014.870036

DO - 10.1586/1744666X.2014.870036

M3 - Review article

VL - 10

SP - 281

EP - 294

JO - Expert Review of Clinical Immunology

JF - Expert Review of Clinical Immunology

SN - 1744-666X

IS - 2

ER -